Your browser doesn't support javascript.
loading
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Pinnix, Chelsea C; Gunther, Jillian R; Dabaja, Bouthaina S; Strati, Paolo; Fang, Penny; Hawkins, Misha C; Adkins, Sherry; Westin, Jason; Ahmed, Sairah; Fayad, Luis; Lee, Hun Ju; Nair, Ranjit; Steiner, Raphael E; Iyer, Swaminathan P; Rodriguez, M Alma; Wang, Michael; Flowers, Christopher; Neelapu, Sattva S; Nastoupil, Loretta J.
Afiliação
  • Pinnix CC; Department of Radiation Oncology and.
  • Gunther JR; Department of Radiation Oncology and.
  • Dabaja BS; Department of Radiation Oncology and.
  • Strati P; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Fang P; Department of Radiation Oncology and.
  • Hawkins MC; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Adkins S; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Westin J; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ahmed S; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Fayad L; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lee HJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Nair R; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Steiner RE; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Iyer SP; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Rodriguez MA; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wang M; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Flowers C; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Neelapu SS; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Nastoupil LJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
Blood Adv ; 4(13): 2871-2883, 2020 07 14.
Article em En | MEDLINE | ID: mdl-32589728
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article